
Cognition Therapeutics, Inc.
CGTXHealthcare|Biotechnology|US
$0.69
+0.05 (+8.12%)
DCF Value
$0.60
Tangible Book / Share
$0.31
Cash / Share
$0.32
Ownership Breakdown
91.9%
Float
95.1M
Shares Outstanding
87.4M
Float Shares
Major Holders (22)
Combined: 51.6%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Aaron G.L. Fletcher | Individual | 6.90% | 6,059,555 | Sep 23, 2025 | 13D/G |
| Bios Capital Management, LP | Partnership | 6.80% | 6,032,328 | Sep 23, 2025 | 13D/G |
| Bios Advisors GP, LLC | Partnership | 6.80% | 6,032,328 | Sep 23, 2025 | 13D/G |
| Cavu Management, LP | Partnership | 6.30% | 5,532,233 | Sep 23, 2025 | 13D/G |
| Cavu Advisors, LLC | Partnership | 6.30% | 5,532,233 | Sep 23, 2025 | 13D/G |
| Leslie W. Kreis | Individual | 6.30% | 5,532,233 | Sep 23, 2025 | 13D/G |
| Bios Equity Partners III, LP | Partnership | 3.00% | 2,658,387 | Sep 23, 2025 | 13D/G |
| Bios Fund III QP, LP | Partnership | 2.30% | 2,021,906 | Sep 23, 2025 | 13D/G |
| Bios Memory SPV I, LP | Partnership | 1.60% | 1,424,014 | Sep 23, 2025 | 13D/G |
| Bios Equity Partners, LP | Partnership | 1.20% | 1,081,531 | Sep 23, 2025 | 13D/G |
| Bios Clinical Opportunity Fund, LP | Partnership | 0.60% | 500,095 | Sep 23, 2025 | 13D/G |
| Bios Equity Cof, LP | Partnership | 0.60% | 500,095 | Sep 23, 2025 | 13D/G |
| Bios Fund I, LP | Partnership | 0.50% | 418,926 | Sep 23, 2025 | 13D/G |
| Bios Memory SPV II, LP | Partnership | 0.40% | 385,248 | Sep 23, 2025 | 13D/G |
| Bios Fund III, LP | Partnership | 0.40% | 309,748 | Sep 23, 2025 | 13D/G |
| Bios Fund III NT, LP | Partnership | 0.40% | 326,733 | Sep 23, 2025 | 13D/G |
| Bios Equity Partners II, LP | Partnership | 0.40% | 368,301 | Sep 23, 2025 | 13D/G |
| Bios Fund I QP, LP | Partnership | 0.30% | 245,029 | Sep 23, 2025 | 13D/G |
| Bios Fund II QP, LP | Partnership | 0.30% | 255,765 | Sep 23, 2025 | 13D/G |
| Bios Fund II, LP | Partnership | 0.10% | 78,298 | Sep 23, 2025 | 13D/G |
| BP Directors, LP | Partnership | 0.04% | 32,328 | Sep 23, 2025 | 13D/G |
| Bios Fund II NT, LP | Partnership | 0.04% | 34,238 | Sep 23, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,951,729 acquired · 266,570 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Khattar Jack A. | director | Jun 17, 2026 | AWARD | 25,000 | — | — | Form 4 |
| Monia Brett P | director | Jun 17, 2026 | AWARD | 25,000 | — | — | Form 4 |
| Wallace Peggy | director | Jun 17, 2026 | AWARD | 25,000 | — | — | Form 4 |
| RICHSTONE ELLEN B | director | Jun 17, 2026 | AWARD | 25,000 | — | — | Form 4 |
| Fletcher Aaron G.L. | director, 10 percent owner: | Jun 17, 2026 | AWARD | 25,000 | — | — | Form 4 |
| Doyle John Brendan | Chief Financial Officer | May 1, 2026 | TAX W/H | 8,567 | $1.28 | $11.0K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Apr 16, 2026 | BUY | 10,000 | $1.13 | $11.3K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Apr 16, 2026 | BUY | 9,175 | $1.10 | $10.1K | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Apr 16, 2026 | BUY | 10,000 | $1.11 | $11.1K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 15, 2026 | TAX W/H | 5,850 | $1.12 | $6.6K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Feb 15, 2026 | TAX W/H | 1,560 | $1.12 | $1.7K | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 15, 2026 | TAX W/H | 4,680 | $1.12 | $5.2K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 3, 2026 | AWARD | 800,000 | — | — | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 3, 2026 | TAX W/H | 26,036 | $1.12 | $29.2K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 4, 2026 | TAX W/H | 51,704 | $1.03 | $53.3K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Feb 3, 2026 | AWARD | 200,000 | — | — | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Feb 4, 2026 | TAX W/H | 26,921 | $1.03 | $27.7K | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 3, 2026 | AWARD | 400,000 | — | — | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 3, 2026 | TAX W/H | 11,488 | $1.12 | $12.9K | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 4, 2026 | TAX W/H | 26,919 | $1.03 | $27.7K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Dec 18, 2025 | AWARD | 75,000 | — | — | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Dec 18, 2025 | TAX W/H | 23,400 | $1.50 | $35.1K | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Dec 18, 2025 | AWARD | 65,000 | — | — | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Dec 18, 2025 | TAX W/H | 20,280 | $1.50 | $30.4K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Dec 18, 2025 | AWARD | 30,000 | — | — | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Dec 18, 2025 | TAX W/H | 9,360 | $1.50 | $14.0K | Form 4 |
| Fletcher Aaron G.L. | director, 10 percent owner: | Sep 19, 2025 | OPTION EX. | 7,729 | $0.84 | $6.5K | Form 4 |
| Fletcher Aaron G.L. | director, 10 percent owner: | Sep 19, 2025 | OPTION EX. | 7,729 | $0.84 | $6.5K | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Jul 29, 2025 | AWARD | 65,000 | — | — | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Jul 29, 2025 | TAX W/H | 20,281 | $0.67 | $13.6K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Jul 29, 2025 | AWARD | 30,000 | — | — | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Jul 29, 2025 | TAX W/H | 9,360 | $0.67 | $6.3K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Jul 29, 2025 | AWARD | 75,000 | — | — | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Jul 29, 2025 | TAX W/H | 23,400 | $0.67 | $15.7K | Form 4 |
| Khattar Jack A. | director | Jun 18, 2025 | AWARD | 34,000 | — | — | Form 4 |
| Wallace Peggy | director | Jun 18, 2025 | AWARD | 34,000 | — | — | Form 4 |
| RICHSTONE ELLEN B | director | Jun 18, 2025 | AWARD | 34,000 | — | — | Form 4 |
| Monia Brett P | director | Jun 18, 2025 | AWARD | 34,000 | — | — | Form 4 |
| Kreis Leslie W. | director, 10 percent owner: | Jun 18, 2025 | AWARD | 34,000 | — | — | Form 4 |
| Fletcher Aaron G.L. | director, 10 percent owner: | Jun 18, 2025 | AWARD | 34,000 | — | — | Form 4 |
| Doyle John Brendan | Chief Financial Officer | May 1, 2025 | TAX W/H | 9,692 | $0.45 | $4.3K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 15, 2025 | TAX W/H | 6,619 | $0.59 | $3.9K | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 15, 2025 | TAX W/H | 5,296 | $0.59 | $3.1K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Feb 15, 2025 | TAX W/H | 1,723 | $0.59 | $1.0K | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 4, 2025 | AWARD | 295,000 | — | — | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 3, 2025 | TAX W/H | 12,779 | $0.67 | $8.5K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Feb 4, 2025 | AWARD | 295,000 | — | — | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 4, 2025 | AWARD | 631,300 | — | — | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 3, 2025 | TAX W/H | 28,960 | $0.67 | $19.3K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Jan 31, 2025 | BUY | 38,851 | $0.77 | $30.0K | Form 4 |
| Kreis Leslie W. | director, 10 percent owner: | Jun 7, 2024 | AWARD | 8,500 | — | — | Form 4 |
| Kreis Leslie W. | director, 10 percent owner: | Jun 7, 2024 | AWARD | 8,500 | $1.95 | $16.6K | Form 4 |
| Fletcher Aaron G.L. | director, 10 percent owner: | Jun 7, 2024 | AWARD | 8,500 | — | — | Form 4 |
| Fletcher Aaron G.L. | director, 10 percent owner: | Jun 7, 2024 | AWARD | 8,500 | $1.95 | $16.6K | Form 4 |
| Wallace Peggy | director | Jun 7, 2024 | AWARD | 8,500 | — | — | Form 4 |
| Wallace Peggy | director | Jun 7, 2024 | AWARD | 8,500 | $1.95 | $16.6K | Form 4 |
| Khattar Jack A. | director | Jun 7, 2024 | AWARD | 8,500 | — | — | Form 4 |
| Khattar Jack A. | director | Jun 7, 2024 | AWARD | 8,500 | $1.95 | $16.6K | Form 4 |
| RICHSTONE ELLEN B | director | Jun 7, 2024 | AWARD | 8,500 | — | — | Form 4 |
| RICHSTONE ELLEN B | director | Jun 7, 2024 | AWARD | 8,500 | $1.95 | $16.6K | Form 4 |
| Monia Brett P | director | Jun 7, 2024 | AWARD | 8,500 | — | — | Form 4 |
| Monia Brett P | director | Jun 7, 2024 | AWARD | 8,500 | $1.95 | $16.6K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | May 1, 2024 | TAX W/H | 8,699 | $1.95 | $17.0K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Mar 14, 2024 | BUY | 5,700 | $1.75 | $10.0K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Feb 15, 2024 | AWARD | 20,000 | — | — | Form 4 |
| Doyle John Brendan | Chief Financial Officer | Feb 15, 2024 | AWARD | 20,000 | $1.98 | $39.6K | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 15, 2024 | AWARD | 60,000 | — | — | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 15, 2024 | AWARD | 60,000 | $1.98 | $118.8K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 15, 2024 | AWARD | 75,000 | — | — | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 15, 2024 | AWARD | 75,000 | $1.98 | $148.5K | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 3, 2024 | TAX W/H | 12,777 | $2.29 | $29.3K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 3, 2024 | TAX W/H | 27,828 | $2.29 | $63.7K | Form 4 |
| Bios Clinical Opportunity Fund, LP | director, 10 percent owner: | Nov 8, 2023 | DISPOSED | 0 | — | — | Form 4 |
| Kreis Leslie W. | director, 10 percent owner: | Nov 8, 2023 | AWARD | 500,095 | $1.05 | $525.1K | Form 4 |
| Fletcher Aaron G.L. | director, 10 percent owner: | Nov 8, 2023 | AWARD | 500,095 | $1.05 | $525.1K | Form 4 |
| Kreis Leslie W. | director, 10 percent owner: | Jun 9, 2023 | AWARD | 6,000 | $2.77 | $16.6K | Form 4 |
| Kreis Leslie W. | director, 10 percent owner: | Jun 9, 2023 | AWARD | 6,000 | — | — | Form 4 |
| Fletcher Aaron G.L. | director, 10 percent owner: | Jun 9, 2023 | AWARD | 6,000 | $2.77 | $16.6K | Form 4 |
| Fletcher Aaron G.L. | director, 10 percent owner: | Jun 9, 2023 | AWARD | 6,000 | — | — | Form 4 |
| Monia Brett P | director | Jun 9, 2023 | AWARD | 6,000 | $2.77 | $16.6K | Form 4 |
| Monia Brett P | director | Jun 9, 2023 | AWARD | 6,000 | — | — | Form 4 |
| Wallace Peggy | director | Jun 9, 2023 | AWARD | 6,000 | — | — | Form 4 |
| Wallace Peggy | director | Jun 9, 2023 | AWARD | 6,000 | $2.77 | $16.6K | Form 4 |
| RICHSTONE ELLEN B | director | Jun 9, 2023 | AWARD | 6,000 | — | — | Form 4 |
| RICHSTONE ELLEN B | director | Jun 9, 2023 | AWARD | 6,000 | $2.77 | $16.6K | Form 4 |
| Khattar Jack A. | director | Jun 9, 2023 | AWARD | 6,000 | — | — | Form 4 |
| Khattar Jack A. | director | Jun 9, 2023 | AWARD | 6,000 | $2.77 | $16.6K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | May 1, 2023 | AWARD | 109,824 | $1.65 | $181.2K | Form 4 |
| Doyle John Brendan | Chief Financial Officer | May 1, 2023 | AWARD | 109,824 | — | — | Form 4 |
| Doyle John Brendan | officer | May 1, 2023 | OTHER | 0 | — | — | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 3, 2023 | AWARD | 94,406 | — | — | Form 4 |
| Caggiano Anthony | Chief Medical Officer | Feb 3, 2023 | AWARD | 94,406 | $2.12 | $200.1K | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 3, 2023 | AWARD | 213,973 | — | — | Form 4 |
| Ricciardi Lisa | director, officer: CEO & President | Feb 3, 2023 | AWARD | 213,973 | $2.12 | $453.6K | Form 4 |
| RICHSTONE ELLEN B | director | Nov 29, 2022 | BUY | 10,000 | $2.65 | $26.5K | Form 4 |
| Fletcher Aaron G.L. | director | Nov 28, 2022 | BUY | 12,220 | $2.65 | $32.4K | Form 4 |
| Fletcher Aaron G.L. | director | Nov 28, 2022 | BUY | 1,973 | $2.65 | $5.2K | Form 4 |
| Fletcher Aaron G.L. | director | Nov 28, 2022 | BUY | 1,871 | $2.65 | $5.0K | Form 4 |
| Kreis Leslie W. | director | Nov 28, 2022 | BUY | 12,220 | $2.65 | $32.4K | Form 4 |
| Kreis Leslie W. | director | Nov 28, 2022 | BUY | 1,973 | $2.65 | $5.2K | Form 4 |